These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

223 related articles for article (PubMed ID: 28158397)

  • 1. Profoundly Expanded T-cell Clones in the Inflamed and Uninflamed Intestine of Patients With Crohn's Disease.
    Doorenspleet ME; Westera L; Peters CP; Hakvoort TBM; Esveldt RE; Vogels E; van Kampen AHC; Baas F; Buskens C; Bemelman WA; D'Haens G; Ponsioen CY; Te Velde AA; de Vries N; van den Brink GR
    J Crohns Colitis; 2017 Jul; 11(7):831-839. PubMed ID: 28158397
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Characterization of T-cell Receptor Repertoire in Inflamed Tissues of Patients with Crohn's Disease Through Deep Sequencing.
    Chapman CG; Yamaguchi R; Tamura K; Weidner J; Imoto S; Kwon J; Fang H; Yew PY; Marino SR; Miyano S; Nakamura Y; Kiyotani K
    Inflamm Bowel Dis; 2016 Jun; 22(6):1275-85. PubMed ID: 27135481
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Expansion of IL-23 receptor bearing TNFR2+ T cells is associated with molecular resistance to anti-TNF therapy in Crohn's disease.
    Schmitt H; Billmeier U; Dieterich W; Rath T; Sonnewald S; Reid S; Hirschmann S; Hildner K; Waldner MJ; Mudter J; Hartmann A; Grützmann R; Neufert C; Münster T; Neurath MF; Atreya R
    Gut; 2019 May; 68(5):814-828. PubMed ID: 29848778
    [TBL] [Abstract][Full Text] [Related]  

  • 4. T Cell Repertoire Homogeneity and Blood-Gut Overlap in Patients With Inflammatory Bowel Disease.
    Williams KG; Kongala R; Shows DM; Konecny AJ; Hindmarch DC; Clarke AS; Lord JD
    Cell Mol Gastroenterol Hepatol; 2024; 17(1):119-130. PubMed ID: 37714427
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Intestinal Receptor of SARS-CoV-2 in Inflamed IBD Tissue Seems Downregulated by HNF4A in Ileum and Upregulated by Interferon Regulating Factors in Colon.
    Verstockt B; Verstockt S; Abdu Rahiman S; Ke BJ; Arnauts K; Cleynen I; Sabino J; Ferrante M; Matteoli G; Vermeire S
    J Crohns Colitis; 2021 Mar; 15(3):485-498. PubMed ID: 32915959
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Reduced numbers of mucosal DR(int) macrophages and increased numbers of CD103(+) dendritic cells during anti-TNF-α treatment in patients with Crohn's disease.
    Dige A; Magnusson MK; Öhman L; Hvas CL; Kelsen J; Wick MJ; Agnholt J
    Scand J Gastroenterol; 2016; 51(6):692-9. PubMed ID: 26784676
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Increased production of granulocyte-macrophage colony-stimulating factor in Crohn's disease--a possible target for infliximab treatment.
    Agnholt J; Kelsen J; Brandsborg B; Jakobsen NO; Dahlerup JF
    Eur J Gastroenterol Hepatol; 2004 Jul; 16(7):649-55. PubMed ID: 15201577
    [TBL] [Abstract][Full Text] [Related]  

  • 8. T cell clonal expansions in ileal Crohn's disease are associated with smoking behaviour and postoperative recurrence.
    Allez M; Auzolle C; Ngollo M; Bottois H; Chardiny V; Corraliza AM; Salas A; Perez K; Stefanescu C; Nancey S; Buisson A; Pariente B; Fumery M; Sokol H; Tréton X; Barnich N; Seksik P; Le Bourhis L;
    Gut; 2019 Nov; 68(11):1961-1970. PubMed ID: 30792246
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Endoscopic response to tumor necrosis factor inhibitors predicts long term benefits in Crohn's disease.
    Alfaro I; Masamunt MC; Planell N; López-García A; Castro J; Gallego M; Barastegui R; Giner A; Vara A; Salas A; Ricart E; Panés J; Ordás I
    World J Gastroenterol; 2019 Apr; 25(14):1764-1774. PubMed ID: 31011260
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Clinical disease activity, C-reactive protein normalisation and mucosal healing in Crohn's disease in the SONIC trial.
    Peyrin-Biroulet L; Reinisch W; Colombel JF; Mantzaris GJ; Kornbluth A; Diamond R; Rutgeerts P; Tang LK; Cornillie FJ; Sandborn WJ
    Gut; 2014 Jan; 63(1):88-95. PubMed ID: 23974954
    [TBL] [Abstract][Full Text] [Related]  

  • 11. [Mucosal healing in different intestinal segments in patients receiving infliximab treatment for small bowel Crohn's disease].
    Zhu ZH; Qiu C; Zhang M; Chen Z; Xiang C; Wang XY
    Nan Fang Yi Ke Da Xue Xue Bao; 2017 Jan; 37(1):44-48. PubMed ID: 28109097
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Proteolytic cleavage and loss of function of biologic agents that neutralize tumor necrosis factor in the mucosa of patients with inflammatory bowel disease.
    Biancheri P; Brezski RJ; Di Sabatino A; Greenplate AR; Soring KL; Corazza GR; Kok KB; Rovedatti L; Vossenkämper A; Ahmad N; Snoek SA; Vermeire S; Rutgeerts P; Jordan RE; MacDonald TT
    Gastroenterology; 2015 Nov; 149(6):1564-1574.e3. PubMed ID: 26170138
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Accuracy of magnetic resonance enterography in assessing response to therapy and mucosal healing in patients with Crohn's disease.
    Ordás I; Rimola J; Rodríguez S; Paredes JM; Martínez-Pérez MJ; Blanc E; Arévalo JA; Aduna M; Andreu M; Radosevic A; Ramírez-Morros AM; Pinó S; Gallego M; Jauregui-Amezaga A; Ricart E; Panés J
    Gastroenterology; 2014 Feb; 146(2):374-82.e1. PubMed ID: 24177375
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Profiles of Lamina Propria T Helper Cell Subsets Discriminate Between Ulcerative Colitis and Crohn's Disease.
    Li J; Ueno A; Fort Gasia M; Luider J; Wang T; Hirota C; Jijon HB; Deane M; Tom M; Chan R; Barkema HW; Beck PL; Kaplan GG; Panaccione R; Qian J; Iacucci M; Gui X; Ghosh S
    Inflamm Bowel Dis; 2016 Aug; 22(8):1779-92. PubMed ID: 27243594
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Mucosal healing of ileal lesions is associated with long-term clinical remission after infliximab maintenance treatment in patients with Crohn's disease.
    Beppu T; Ono Y; Matsui T; Hirai F; Yano Y; Takatsu N; Ninomiya K; Tsurumi K; Sato Y; Takahashi H; Ookado Y; Koga A; Kinjo K; Nagahama T; Hisabe T; Takaki Y; Yao K
    Dig Endosc; 2015 Jan; 27(1):73-81. PubMed ID: 24833527
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Location but Not Severity of Endoscopic Lesions Influences Endoscopic Remission Rates in Crohn's Disease: A Post Hoc Analysis of TAILORIX.
    Rivière P; D'Haens G; Peyrin-Biroulet L; Baert F; Lambrecht G; Pariente B; Bossuyt P; Buisson A; Oldenburg B; Vermeire S; Laharie D
    Am J Gastroenterol; 2021 Jan; 116(1):134-141. PubMed ID: 33177349
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Reduced diversity of intestinal T-cell receptor repertoire in patients with Crohn's disease.
    Hong SN; Park JY; Yang SY; Lee C; Kim YH; Joung JG
    Front Cell Infect Microbiol; 2022; 12():932373. PubMed ID: 36034703
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Effect of tight control management on Crohn's disease (CALM): a multicentre, randomised, controlled phase 3 trial.
    Colombel JF; Panaccione R; Bossuyt P; Lukas M; Baert F; Vaňásek T; Danalioglu A; Novacek G; Armuzzi A; Hébuterne X; Travis S; Danese S; Reinisch W; Sandborn WJ; Rutgeerts P; Hommes D; Schreiber S; Neimark E; Huang B; Zhou Q; Mendez P; Petersson J; Wallace K; Robinson AM; Thakkar RB; D'Haens G
    Lancet; 2017 Dec; 390(10114):2779-2789. PubMed ID: 29096949
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Identification of inflammatory mediators in patients with Crohn's disease unresponsive to anti-TNFα therapy.
    Leal RF; Planell N; Kajekar R; Lozano JJ; Ordás I; Dotti I; Esteller M; Masamunt MC; Parmar H; Ricart E; Panés J; Salas A
    Gut; 2015 Feb; 64(2):233-42. PubMed ID: 24700437
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Infliximab treatment induces apoptosis of lamina propria T lymphocytes in Crohn's disease.
    ten Hove T; van Montfrans C; Peppelenbosch MP; van Deventer SJ
    Gut; 2002 Feb; 50(2):206-11. PubMed ID: 11788561
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 12.